SC-PEG Asparaginase vs. Oncaspar in Pediatric Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma

NCT01574274 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia
Lymphoblastic Lymphoma

Interventions

DRUG: SC-PEG
DRUG: Oncaspar

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]